Conseil d'examen du prix des médicaments brevetés - Patented Medicine Prices Review Board Canada Wordmark
 
 Français  Contact Us  Help  Search  Canada Site
Home About the
 PMPRB
Order Forms
Feedback
Sitemap
Archives
 Other Sites

Home > Help Printer Friendly
Site Map

 Home
     Frequently Asked Questions
      Legislation, Regulations and Guidelines
          Patent Act
          Patented Medicines Regulations, 1994
          Compendium of Guidelines, Policies and Procedures
          Compendium of Guidelines, Policies and Procedures1
          Patentee's Guide to Reporting
      Regulatory
          Advance Ruling Certificate
          Advisory Notes
           Filing Requirements Clarification
               Patentees' Guide to Reporting
               Filing Requirements
               Filing Requirements: Patent Pending Policy
               Filing Requirements: Reporting Domestic Sales
               Implementation of the Use of the FSS Prices in International Price Comparaisons
               Peer-Reviewed Studies in the PMPRB’s Price Review Process
               Price Increases – Monitoring Compliance with the Guidelines
               PMPRB Price Guidelines: 2004 Price Increases
          Hearings
           Patented Medicines
               New Patented Medicines Introduced in:
               Reports on New Patented Drugs for Human Use:
               Reports on New Patented Drugs for Veterinary Use:
               Patented Drug Products for Human Use and Canadian Patentees:
          Volutary Compliance Undertakings
      Reporting
          Annual Reports (2000 to 2005)
          Non-Patented Prescription Drug Prices
          National Prescription Drug Utilization Information System (NPDUIS)
          Study Series and Discussion Papers
      Consultations
          Consultations on the Board's Excessive Price Guidelines
          Notice and Comments
          Research Agenda
          Road Map for the Next Decade
           Events
               Upcoming Events
               Speech Series
      Publications
          Advisory Notes
          Annual Reports
          Articles
          NEWSletter
          Speech Series
          Study Series and Discussion Papers
          Summary of Board Meetings
     Reports to Parliament
     Hospitality and Travel Expenses
     Contracts
     Disclosure of Position Reclassifications
     Grant and Contribution Awards Over $25,000


Last Updated: 2004-05-31 Arrow Important Notices